Literature DB >> 19265646

Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.

Alexander Tschoner, Julia Engl, Maria A Rettenbacher, Susanne Kaser, Helmut W Ott, W Wolfgang Fleischhacker, Josef R Patsch, Christoph F Ebenbichler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19265646     DOI： 10.4088/jcp.08l04509

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  4 in total

1.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

2.  PROLACTIN LEVEL IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA TREATED FOR ONE YEAR WITH ATYPICAL ANTIPSYCHOTICS.

Authors:  V P Matei; T Purnichi; A Mihailescu; R Grigoras
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

Review 3.  The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Authors:  J Peuskens; L Pani; J Detraux; M De Hert
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

4.  Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.

Authors:  Nedjeljka Ruljancic; Ana Bakliza; Sandra Vuk Pisk; Natko Geres; Katarina Matic; Ena Ivezic; Vladimir Grosic; Igor Filipcic
Journal:  Biochem Med (Zagreb)       Date:  2020-12-15       Impact factor: 2.313
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.